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Objectives: The increase in resistance of methicillin resistant Staphylococcus aureus (MRSA) strains to
vancomycin has been perceived as a formidable threat in the therapeutic ﬁelds. The present study
investigated the vancomycin resistance traits of MRSA isolates [vancomycin resistant S. aureus (VRSA)]
collected from burn patients.
Materials and Methods: Twenty-nine of 40 isolates of Staphylococcus spp. were identiﬁed as S. aureus
which were further tested against 20 commercially available antibiotics to determine antibiotic sus-
ceptibility patterns.
Results: Imipenem was the most potential antibiotic resulting in 90% sensitivity, followed by netilmicin,
clindamycin, and nitrofurantoin (80% sensitivity). All isolates were found to be resistant to penicillin.
Approximately 75% of them were found to be resistant to methicillin, oxacillin, azithromycin, cipro-
ﬂoxacin, and tetracycline. Approximately 45% isolates exhibited resistance to amikacin, chloramphenicol,
gentamycin, and tobramycin. Twenty-one of the 29 strains of S. aureus were MRSA, of which 11 were
resistant to vancomycin when employing the disc diffusion method. However, when the broth micro-
dilution procedure was used to measure the minimum inhibitory concentration (MIC) of vancomycin,
eight isolates were resistant to vancomycin, six with an MIC of 32 mg/ mL and two with an MIC of
64 mg/mL.
Conclusion: A signiﬁcant fraction of VRSA was found among MRSA strains in this study, revealing the
necessity for new and effective drugs against MRSA.
Copyright © 2016, Buddhist Compassion Relief Tzu Chi Foundation. Published by Elsevier Taiwan LLC.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).1. Introduction
Over the past few decades, there has been an alarming increase
in the prevalence of antibiotic resistant pathogens and strains in
serious infections [1e11]. The occurrence of bacterial infection had
decreased with the discovery of penicillin in 1940 until Staphylo-
coccus aureus began producing b-lactamase, which destroys the
penicillin b-lactam core ring [11,12]. This increase in resistance to-
wards penicillin drove the development of methicillin drugs, which
are virtually resistant against many genetic variations of theiology, Stamford University
desh. Tel.: þ880 2 835 5626,
.
lief Tzu Chi Foundation. Publishedb-lactamase enzyme. Infection by S. aureus was well controlled
using methicillin until the isolation of the ﬁrst strain of methicillin
resistant S. aureus (MRSA) in 1961 [1,12,13]. Since then, MRSA has
become endemic in hospitals and nursing homes worldwide
[1,3,7,14].
Burn patients are susceptible to infection, especially skin and
soft tissue infections such as burn wound impetigo, burn wound
cellulitis, and invasive types infection, because of their impaired
immune system. Hence hospital-associated strains of MRSA have
become a great concern, mostly due to treatment failure [7].
S. aureus was noted in the skin and mucosa of up to 40% of all burn
patients of which 30% had severe cases of toxic shock [4,15,16]. In
one study, the frequency of S. aureus infection reached 47% in burn
patients and the prevalence of MRSA was up to 45% [15]. Although
vancomycin has been the most reliable therapeutic agent against
infections caused by MRSA, there has been an alarming emergenceby Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license
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widespread use of vancomycin to treat infections caused by MRSA;
(2) a patient's immune status; (3) surgical procedures; and (4)
involvement of healthcare workers infected with MRSA [17e23].
With the increasing resistance of S. aureus as well as the emergence
of multidrug resistant strains, the choice of medication remains one
of the most challenging concerns in the burn management unit.
Although nosocomial infections are associated with remarkable
morbidity and mortality both in developed and developing coun-
tries, information concerning such infections in Bangladesh in the
international literature is limited [4,7]. The detection rates of MRSA
in hospitals in different cities in Bangladesh were recently reported
to be 32e63%, which is high compared with the United States and
European countries [18]. In this context, information on the anti-
microbial susceptibility patterns of MRSA could help in the selec-
tion of appropriate treatment. Based on this rationale, the current
study investigated the occurrence of MRSA strains in burn patients
and the susceptibility patterns of these strains against various an-
tibiotics used to treat hospitalized patients in Bangladesh.
2. Materials and methods
2.1. Study area, sampling, and sample processing
The experiment was carried out in the Microbiology Laboratory
of the Department of Microbiology, Stamford University
Bangladesh, Dhaka, Bangladesh from April 23, 2012 to January 15,
2013. A total of 40wound samples from patients with tertiary burns
of partial or full thickness (deep reticular dermis) were collected
aseptically with a sterile cotton swab by a clinician wearing gloves
(US Safety & Supply Co.) and a mask in the burn unit of Dhaka
Medical College Hospital, Dhaka, Bangladesh [7,24]. The patients
were under treatment with antibiotics including trimetho-
primesulfamethoxazole, methicillin, and ceftriaxone (Oxoid, UK).
All patients were men aged between 20 years and 45 years from a
lower middle-class community. The samples were inoculated on
Mannitol salt agar (MSA) (HiMedia, India) plates immediately after
sample collection for isolation of S. aureus and transported to the
laboratory as early as possible [19,23,25].
2.2. Isolation and identiﬁcation of Staphylococcus aureus
All MSA plates were incubated for 24 hours at 37C. After in-
cubation, isolated colonies suspected to be Staphylococcus were
allowed to grow on nutrient agar plates (HiMedia, India) and then
identiﬁed microscopically, biochemically, and serologically [19,20].
For microscopic observation, a pure colony was selected and sub-
jected to Gram staining. Then the shape, arrangement, and Gram
reactions of the isolates were observed under a light microscope
(Max-plank- Ring 21 D-65205, Wiesbaden, Germany) (at a magni-
ﬁcation of 100) [25]. Required conﬁrmatory biochemical tests
including catalase and triple sugar iron agar tests were performed
to identify suspected S. aureus following standard protocols [25].
2.3. Hemolytic activity and coagulase test
The hemolytic activity of S. aureus isolates was tested using
blood agar plates containing 5% deﬁbrinated sheep blood. An iso-
lated colony from a nutrient agar (NA) plate was inoculated on
blood agar and incubated at 37C for 24 hours. The hemolytic zones
were characterized as a (partial hemolysis), b (complete hemoly-
sis), and g (no hemolysis) depending on the extent of each colony
[25]. A coagulase test (Becton Dickinson Microbiology Systems,
USA) was performed to differentiate the hospital-acquired isolates.
For this purpose, 10 mL of the antiserumwas placed on the slide anda suspension of the organism was added. Agglutination was
observed against light and the results were recorded [25].
2.4. Assay of antibacterial susceptibility
A standard agar-disc diffusion (KirbyeBauer) assay using
MuellereHinton agar (MHA) (HiMedia, India) plates was conducted
to determine the susceptibility of the isolated S. aureus to different
antibiotics [26e28]. A suspension of the test organism was pre-
pared by adjusting the turbidity of the broth in phosphate buffer
saline by comparing with that of the McFarland standard solution
of 0.5 [27,28]. By means of a sterile cotton swab, a uniform lawn of
bacterial growth was prepared on the MHA plates. A total of 20
antibiotic discs including amikacin (30 mg), azithromycin (15 mg),
ceftriaxone (30 mg), cefoxitin (30 mg), cephradine (30 mg), chlor-
amphenicol (30 mg), ciproﬂoxacin (5 mg), clindamycin (2 mg),
erythromycin (15 mg), gentamycin (10 mg), imipenem (10 mg),
methicillin (5 mg), netilmicin (30 mg), nitrofurantoin (300 mg),
oxacillin (1 mg), penicillin (10 mg), tetracycline (30 mg), tobramycin
(10 mg), trimethoprim/sulfamethoxazole (25 mg), and vancomycin
(30 mg) were applied aseptically on the surface of the inoculated
plates in an appropriate spatial arrangement using a sterile needle.
The plates were incubated at 37C for 12e18 hours and examined
for zones of inhibition (mm) [26,29].
2.5. Identiﬁcation of MRSA
For the detection of MRSA, oxacillin (1 mg) and methicillin (5 mg)
were introduced on the MHA plates against the growth of S. aureus.
For this purpose, a bacterial suspension was prepared in sterile
saline by selecting colonies produced by overnight incubation on
NA agar plates. After 5e7 hours of incubation, the cell turbidity was
adjusted to 0.5 McFarland standards [27,28]. Subsequently, the
suspensions were inoculated onto MHA plates and the antibiotic
discs were then placed onto the plates [20,21]. All plates were
incubated for 24 hours at 37oC to observe for oxacillin and methi-
cillin resistant S. aureus.
2.6. Identiﬁcation of VRSA through disc diffusion methods
MHA plates were inoculated with the bacterial suspension
which was previously adjusted to 0.5 McFarland standards. After-
ward, a 30 mg vancomycin disc and a blank disc as a control were
aseptically placed over the surface of the MHA plates at a distance
of 5 mm to observe the range of the zone diameter for the detection
of strains of VRSA [20,21].
2.7. Determination of vancomycin resistance by minimum
inhibitory concentration test
The minimum inhibitory concentration (MIC) of vancomycin
(Oxoid, UK) was determined by the tube dilution method
[7,30e32]. MullereHinton Broth was prepared with 4e512 mg/mL
of vancomycin. By using a direct colony suspension method, 0.5
McFarland equivalent bacterial inoculums were prepared in normal
saline after culturing for 24 hours on an agar plate. The suspension
was further diluted to achieve the desired inoculum concentration.
All strains were spotted onto MullereHinton plates containing
different concentrations of vancomycin. The plates were incubated
for 24 hours at 37C and checked for any visible growth [26].
3. Results
In recent years, Staphylococcus aureus has become one of
the most dangerous pathogens due to its increased resistance to
Table 1
Biochemical determination of the presumptively selected Staphylococcus aureus.a
Isolates ID Catalase test TSI Hemolytic activity Coagulase test
Slant Butt
S-1 þ A A b þ
S-2 þ A A b þ
S-3 þ A A b þ
S-4 þ A A b þ
S-5 þ A A b þ
S-6 þ A A a þ
S-8 þ A A b þ
S-9 þ A A b þ
S-10 þ A A b þ
S-11 þ A A b þ
S-12 þ A A b þ
S-14 þ A A b þ
S-16 þ A A b þ
S-18 þ A A b þ
S-19 þ A A b þ
S-20 þ A A b þ
S-21 þ A A b þ
S-22 þ A A b þ
S-23 þ A A b þ
S-24 þ A A b þ
S-25 þ A A b þ
S-26 þ A A b þ
S-27 þ A A b þ
S-28 þ A A a þ
S-29 þ A A b þ
S-30 þ A A b þ
S-31 þ A A b þ
S-32 þ A A b þ
S-33 þ A A b þ
A ¼ acidic reaction; S ¼ Staphylococcus aureus isolates; TSI ¼ Triple Sugar Iron.
a All the experiments were performed in triplicates and the results were
reproducible.
Fig. 1. Resistance and susceptibility patterns of Staphylococcus aureus towards commonly u
cefoxitin (30 mg), cephradine (30 mg), chloramphenicol (30 mg), ciproﬂoxacin (5 mg), clindamyc
netilmicin (30 mg), nitrofurantoin (300 mg), oxacillin (1 mg), penicillin (10 mg), tetracycline (30 m
Among 20 tested antibiotics, imipenem was found to be the potent antibiotic against all isol
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MRSA is a causative agent of hospital-acquired infection and an
incipient community pathogen in many geographical regions
[13,36e38]. In the present study, the isolation rate of S. aureus
(72.5%) from burn wound patients was high, as the microorganism
was conﬁrmed in 29 of the 40 isolated strains of Staphylococcus spp.
based on cultural, biochemical, and coagulase properties (Table 1).
In addition, imipenemwas found to be the most effective antibiotic
against the isolates with 90% of strains exhibiting sensitivity to this
drug (Fig. 1). Most of the isolates (80%) were also sensitive to
netilmicin, clindamycin, and nitrofurantoin. For vancomycin, 62% of
isolates showed sensitivity. Almost 55% of isolates were sensitive to
amikacin, chloramphenicol, gentamycin, and tobramycin. However,
26 of 29 strains of S. aureuswere resistant to penicillin G and 75% of
isolates were resistant to azithromycin, ciproﬂoxacin, methicillin,
oxacillin, and tetracycline. Approximately 65% of isolates exhibited
resistance to erythromycin, and trimethoprimesulfamethoxazole
(Fig. 1).
Twenty-one of the 29 S. aureus isolates studied were found to be
MRSA (Table 2). The prevalence of methicillin resistance among
staphylococci isolated from burn patients in our hospital has not
been determined accurately to date. In this study, the prevalence of
MRSA was 72% (Table 2), which varied from ﬁndings in other
studies in other countries. In three separate studies in Iran, 56%,
72%, and 58% of staphylococci were identiﬁed as methicillin resis-
tant [39e41]. Interestingly, a study in Korea in 2001 showed that
the incidence of MRSA in burn cases could be as high as up to 98%
[42]. A study in the United States in 2006 showed the rate of MRSA
in a burn center was 33% [43]. Therapeutic strategies for severe
MRSA infections are indeed limited to a few antibiotics including
vancomycin. Thus the acquisition of high-level vancomycinsed antibiotics including amikacin (30 mg), azithromycin (15 mg), ceftriaxone (30 mg),
in (2 mg), erythromycin (15 mg), gentamicin (10 mg), imipenem (10 mg), methicillin (5 mg),
g), tobramycin (10 mg), trimethoprim/ sulfamethoxazole (25 mg), and vancomycin (30 mg).
ated S. aureus. However, 90% of strains exhibited resistance to penicillin G.
Table 2
Detection of methicillin resistant Staphylococcus aureus (MRSA).a
No of isolates Antibiotics Resistant presence (%)
n ¼ 21 (out of 29) Oxacillin & methicillin
S-2 R 72%
S-3 R
S-4 R
S-5 R
S-6 R
S-8 R
S-9 R
S-10 R
S-12 R
S-14 R
S-21 R
S-23 R
S-24 R
S-25 R
S-26 R
S-27 R
S-28 R
S-29 R
S-31 R
S-32 R
S-33 R
R ¼ resistant.
a All the experiments were performed in triplicates and the results were
reproducible.
Table 4
Determination of vancomycin susceptibility pattern (VRSA, VISA & VSSA) of Staph-
ylococcus aureus through minimal inhibitory concentration (MIC).a
S. aureus
strain
Vancomycin
MIC (mg/mL)
Vancomycin
phenotype
Resistant
presence (%)
S-21 32 VRSA 28%
S-23 32
S-25 64
S-26 32
S-27 64
S-28 32
S-31 32
S-33 32
S-1 8 VISA 55%
S-2 8
S-3 8
R. Hasan et al. / Tzu Chi Medical Journal 28 (2016) 49e5352resistance by MRSA is a major health concern. Genomic studies
have provided information on the evolutionary history of VRSA and
identiﬁed genetic features that may focus on the acquisition
mechanism of vancomycin resistance genes [37e44].
To determine vancomycin resistance among isolated MRSA in
the current study, S. aureus strains were further tested using both
agar disc diffusion and broth microdilution procedures (MIC). A
total of 11 of theMRSA isolates (S-8, S-9, S-14, S-21, S-23, S-25, S-26,
S-27, S-28, S-31, and S-33) were resistant to vancomycin with the
disc diffusion method (Table 3). Subsequently, MIC assay showed
that eight strains of S. aureus (28%) were resistant to vancomycin.
Two of these strains had MIC values of 64 mg/mL and the other six
strains had MIC values of 32 mg/mL, which were deﬁned as VRSA in
accordance with the laboratory breakpoints published by the
Clinical and Laboratory Standards Institute [45]. Interestingly,
among 29 samples 16 strains were noted to be vancomycin inter-
mediate S. aureus (VISA), eight strains with MIC values of 8 mg/mL
and another eight strains with MIC values of 16 mg/mL, and ﬁve
samples were vancomycin sensitive S. aureus (VSSA) with MICTable 3
Identiﬁcation of vancomycin resistant Staphylococcus aureus (VRSA) among MRSA
through disc diffusion method.a
No of isolates Antibiotic Resistant presence (%)
n ¼ 11 (out of 21) Vancomycin
S-8 R 52%
S-9 R
S-14 R
S-21 R
S-23 R
S-25 R
S-26 R
S-27 R
S-28 R
S-31 R
S-33 R
R ¼ resistant.
a All the experiments were performed in triplicates and the results were
reproducible.values of 5 mg/mL (Table 4). We assume the MIC values of vanco-
mycin for these 21 MRSA isolates varied because of different levels
of expression of the vanA gene in these isolates or other mecha-
nisms [46,47].
In the past few years, several antibiotics have been noted to be
less effective in the context of disease mitigation worldwide, as
an array of pathogenic microorganisms are gradually becoming
resistant to these therapeutic agents [48]. This raises the possi-
bility of greatly increased mortality from simple infections and
treatment-mediated failures. Along with multi-drug resistant
(MDR) and extensively-drug resistant Mycobacterium tuberculosis,
the MRSA strains, VRSA strains, coagulase-negative staphylococci,
glycopeptide intermediate sensitive S. aureus, vancomycin-
resistant Enterococcus species, penicillin-resistant Streptococcus
pneumoniae, and the extended-spectrum b-lactamase producing
bacteria are highly prominent [48]. In Bangladesh, recent studies
of burn patients revealed huge growth in aerobic viable bacteria
including Pseudomonas spp., S. aureus, and Klebsiella spp, Enter-
obacter spp. and Escherichia coli of which most were found to be
MDR [7,14]. The current ﬁndings on the prevalence of VRSA
strains among MRSA isolates further demonstrates the necessity
for research emphasis on the microbiology of burn injuries,
which in turn, could enhance the overall treatment of burns
[7,14].
The major drawback of this study was the lack of molecular
characterization of the isolates and detection of virulent genes,
which could be investigated in future research. Such study may
help physicians generate new treatment policies as well as to
develop new drugs against the resistant properties of isolates.S-4 16
S-6 16
S-8 16
S-10 8
S-11 8
S-12 16
S-14 16
S-16 8
S-19 8
S-29 16
S-30 16
S-32 16
S-33 8
S-5 5 VSSA 17%
S-9 5
S-18 5
S-20 5
S-22 5
MIC ¼ minimal inhibitory concentration, VISA ¼ vancomycin intermediate Staph-
ylococcus aureus, VRSA ¼ vancomycin resistant Staphylococcus aureus,
VSSA ¼ vancomycin sensitive Staphylococcus aureus.
a All the experiments were performed in triplicates and the results were
reproducible.
R. Hasan et al. / Tzu Chi Medical Journal 28 (2016) 49e53 53The current study revealed a high percentage of VISA isolates
compared with VRSA and VSSA in isolated MRSA, highlighting the
necessity for local or country-based investigations to characterize
and monitor MRSA and to develop strategies that will accelerate
MRSA management and control. In our study, imipenemwas found
to be the most effective drug against MRSA. In addition, the
application of antibiotic combination therapy against VISA and
VRSA, and maintenance of proper hygiene by hospitalized patients
and staff could effectively reduce the rate and dissemination of
such cases. Further molecular studies are required to identify
resistance-conferring genes.Acknowledgments
We thank the Microbiology Laboratory, Stamford University
Bangladesh for the technical facilities.References
[1] BrownD,EdwardsD,HawkeyP,MorrisonD,RidqwayG,TownerK,etal.Guidelines
for the laboratory diagnosis and susceptibility testing of methicillin-resistant
Staphylococcus aureus (MRSA). Antimicrob Agents Chemother 2005;65:1000e8.
[2] Chessa D, Ganau G, Mazzarello V. An overview of Staphylococcus epidermidis
and Staphylococcus aureus with a focus on developing countries. J Infect Dev
Ctries 2015;9:547e50.
[3] Jones RN. Key considerations in the treatment of complicated Staphylococcal
infections. Clin Microbiol Infect 2008;14:3e9.
[4] Dutta S, Hassan MR, Rahman F, Jilani MFA, Noor R. Study of antimicrobial
susceptibility of clinically signiﬁcant microorganisms isolated from selected
areas of Dhaka, Bangladesh. Bang J Med Sci 2013;12:34e42.
[5] Noor R, Hossain A, Munshi SK, Rahman F, Kamal SM. Slide drug susceptibility
test for the detection of multi-drug resistant tuberculosis in Bangladesh.
J Infect Chemother 2013;19:818e24.
[6] Noor R, Akhter S, Rahman F, Munshi SK, Kamal SMM, Feroz F. Frequency of
extensively drug resistant tuberculosis (XDR-TB) among retreatment cases in
NIDCH, Dhaka, Bangladesh. J Infect Chemother 2013;19:243e8.
[7] Alam SMS, Kalam MA, Munna MS, Munshi SK, Noor R. Isolation of pathogenic
microorganisms from burn patients admitted in Dhaka Medical Collage and
Hospital and demonastration of their drug-resistant traits. Asian Pac J Trop Dis
2014;4:402e7.
[8] Aurin TH, Munshi SK, Kamal SM, Rahman MM, Hossain MS, Marma T, et al.
Molecular approaches for detection of the multi-drug resistant tuberculosis
(MDR-TB) in Bangladesh. PLoS ONE 2014;9:e99810.
[9] Molton JS, Tambyah PA, Ang BSP, Ling ML, Fisher DA. The global spread of
healthcare-associated multidrug-resistant bacteria: a perspective from Asia.
Clinical Infec Dis 2013;6:1310e8.
[10] Tenover FC. Mechanisms of antimicrobial resistance in bacteria. Am J Med
2006;119:3e10.
[11] Khan SA, Feroz F, Noor R. Study of extended spectrum b-lactamase producing
bacteria from urinary tract infection in Dhaka city, Bangladesh. Tzu Chi Med J
2013;25:39e42.
[12] Peacock S. Staphylococcus aureus. In: Gillespie S, Hawkey P, editors. Principle
and practice of clinical bacteriology. 2nd ed. England: John Wiley and Sons
Ltd; 2006. p. 620.
[13] Lowy F. Staphylococcal infections. In: Fauci A, Braunwarld E, Kasper D,
Hauser S, Longo D, Jameson J, editors. Harrison's principles of internal med-
icine. 16th ed. New York: MacGraw-Hill Companies; 2005. p. 2958.
[14] Noor R, Munna MS. Emerging diseases in Bangladesh: current microbiological
research. Tzu Chi Med J 2015;27:49e53.
[15] Bagdonas R, Tamelis A, Rimdeika R. Staphylococcus aureus infection in the
surgery of burns. Medicina 2003;39:1078e81.
[16] Matsushima A, Kuroki Y, Nakajima S, Sakai T, Kojima H, Ueyama M. Low level
of TSST-1 antibody in burn patients with toxic shock syndrome caused by
methicillin-resistant Staphylococcus aureus. J Burn Care Res 2015;36:e120e4.
[17] Montazeri EA, Khosravi AD, Jolodar A, Ghaderpanah M, Azarpira S. Identiﬁ-
cation of methicillin-resistant Staphylococcus aureus (MRSA) strains isolated
from burn patients by multiplex PCR. Burns 2015;41:590e4.
[18] Haq JA, Rahman MM, Haque Asna SM, Hossain MA, Ahmed I, Haq T, et al.
Methicillin-resistant Staphylococcus aureus in Bangladeshda multi centre
study. Int J Antimicro Agents 2005;25:276e7.
[19] Abdel Rahman AT, Hafez SF, Abdelhakam SM, Ali-Eldin ZA, Esmat IM,
Elsayed MS, et al. Antimicrobial resistant bacteria among healthcare workers
in intensive care units at Ain Shams University Hospitals. J Egypt Soc Parasitol
2010;40:71e83.
[20] Kaiser ML, Thompson DJ, Malinoski D, Lane C, Cinat ME. Epidemiology and
risk factors for hospital-acquired methicillin-resistant Staphylococcus aureus
among burn patients. J Burn Care Res 2011;32:429e34.[21] Schweizer M, Ward M, Cobb S, McDanel J, Leder L, Wibbenmeyer L, et al. The
epidemiology of methicillin-resistant Staphylococcus aureus on a burn trauma
unit. Infect Control Hosp Epidemiol 2012;33:1118e25.
[22] Chen X, Yang HH, Huangfu YC, Wang WK, Liu Y, Ni YX, et al. Molecular
epidemiologic analysis of Staphylococcus aureus isolated from four burn cen-
ters. Burns 2012;38:738e42.
[23] Wibbenmeyer L, Williams I, Ward M, Xiao X, Light T, Latenser B, et al. Risk
factors for acquiring vancomycin-resistant Enterococcus and methicillin-
resistant Staphylococcus aureus on a burn surgery step-down unit. J Burn
Care Res 2010;31:269e79.
[24] American Public Health Association. Standard Methods for the Examination of
Water and Wastewater. Washington DC: American Public Health Association;
1998.
[25] Cappuccino JG, Sherman N. Microbiology - A laboratory manual. 5th ed. Menlo
Park, (CA): The Benjamin/Cummings Publishing Co., Inc.; 1996.
[26] Sharmin M, Nur IT, Acharjee M, Munshi SK, Noor R. Microbiological proﬁling
and the demonstration of in vitro antibacterial traits of the major oral herbal
medicines used in Dhaka Metropolis. SpringerPlus 2014;3:739.
[27] Ferraro MJ, Craig WA, Dudley MN, Eliopoulos GM, Hecht DW, Hindler J, et al.
Performance standards for antimicrobial disk susceptibility tests. Approved
Standard M2-A7. 7th ed. Wayne (PA): National Committee for Clinical Labo-
ratory Standards; 2000.
[28] Bauer AW, Kirby WMM, Sherris JC, Tierch M. Antibiotic susceptibility testing
by a standardized single disc method. Am J Clin Pathol 1968;45:493e6.
[29] Munshi SK, Rahman MM, Noor R. Detection of virulence potential of diar-
rheagenic Escherichia coli isolated from surface water of rivers surrounding
Dhaka City. J Bang Acad Sci 2012;36:109e22.
[30] Clinical and Laboratory Standards Institute (CLSI). Methods for dilution anti-
microbial susceptibility tests for bacteria that grow aerobically: Approved
Standard-7th Edition. Wayne (PA): CLSI; 2006.
[31] Clinical and Laboratory Standards Institute (CLSI). Performance standards for
antimicrobial susceptibility testing; 19th informational supplement. CLSI
M100eS19 Clinical and Laboratory Standards Institute. Wayne (PA): CLSI;
2009.
[32] National Committee for Clinical Laboratory Standards (NCCLS). Methods for
dilution antimicrobial susceptibility tests for bacteria that grow aerobically.
Approved standard M7eA5. 5th ed. Wayne (PA): NCCLS; 2000.
[33] Kuehnert MJ. Staphylococcal disease burden. J Infect Dis 2006;193:172e9.
[34] Gardete S, Tomasz A. Mechanisms of vancomycin resistance in Staphylococcus
aureus. J Clin Invest 2014;124:2836e40.
[35] Fri~aes A, Resina C, Manuel V, Lito L, Ramirez M, Melo-Cristino J. Epidemio-
logical survey of the ﬁrst case of vancomycin-resistant Staphylococcus aureus
infection in Europe. Epidemiol Infect 2015;143:745e8.
[36] Treatment of bacteraemia: meticillin-resistant Staphylococcus aureus (MRSA)
to vancomycin-resistant S. aureus (VRSA). Gould IM. Int J Antimicrob Agents
2013;42(Suppl):S17e21.
[37] Kobayashi SD, Musser JM, DeLeo FR. Genomic analysis of the emergence of
vancomycin-resistant Staphylococcus aureus. MBio 2012;3:e00170e12.
[38] Cesur S, Irmak H, Sims¸ek H, C€oplü N, Kılıç H, Arslan U, et al. Evaluation of
antibiotic susceptibilities and VISA-VRSA rates among MRSA strains isolated
from hospitalized patients in intensive care units of hospitals in seven prov-
inces of Turkey. Mikrobiyol Bul 2012;46:352e8.
[39] Japoni A, Alborzi AV, Rasouli M, Pourabbas B. Modiﬁed DNA extraction for
rapid PCR detection of methicillin resistant Staphylococci. Iranian Biomed J
2004;8:61e5.
[40] Mehdinejad M, Frajzade A, Jolodar A. Study of methicillin resistance in
Staphylococcus aureus and species of coagulase negative staphylococci isolated
from various clinical specimens. Pak J Med Sci 2008;24:115e7.
[41] Ekrami A, Kalantar E. Bacterial infections in burn patients at a burn hospital in
Iran. Indian J Med Res 2007;126:541e4.
[42] Song W, Lee K, Kang H, Hoon Shin D. Microbiologic aspects of predominant
bacteria isolated from the burn patients in Korea. Burns 2001;27:136e9.
[43] Hodle AE, Richter KP, Thompson RM. Infection control practices in US burn
units. Mol Biol Rep 2006;27:142e51.
[44] Kos VN, Desjardins CA, Griggs A, Cerqueira G, Van Tonder A, Holden MT, et al.
Comparative genomics of vancomycin-resistant Staphylococcus aureus strains
and their positions within the clade most commonly associated with
methicillin-resistant S. aureus hospital-acquired infection in the United States.
MBio 2012;3:e00112e12.
[45] Clinical and Laboratory Standards Institute (CLSI). Standards for antimicrobial
susceptibility testing performance; 16th informational supplement. CLSI
M100eS16 Clinical and Laboratory Standards Institute (formerly NCCLS).
Wayne (PA): CLSI; 2006.
[46] Qureshi NK, Yin S, Boyle-Vavra S. The role of the staphylococcal VraTSR
regulatory system on vancomycin resistance and vanA operon expres-
sion in vancomycin-resistant Staphylococcus aureus. PLoS One 2014;9:
e85873.
[47] Apfalter P. MRSA/MRSE-VISA/GISA/VRSA-PRP-VRE: current Gram-positive
problem bacteria and mechanism of resistance, prevalence, and clinical con-
sequences. Wien Med Wochenschr 2003;153:144e7.
[48] Noor R, Zerin N, Das KK. Microbiological quality of pharmaceutical products in
Bangladesh: current research perspective. Asian Pac J Trop Dis 2015;5:
264e70.
